Growth Metrics

Repligen (RGEN) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Repligen (RGEN) over the last 15 years, with Q3 2025 value amounting to $2.9 billion.

  • Repligen's Liabilities and Shareholders Equity rose 328.78% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 billion, marking a year-over-year increase of 110.37%. This contributed to the annual value of $2.8 billion for FY2024, which is 5.37% down from last year.
  • Per Repligen's latest filing, its Liabilities and Shareholders Equity stood at $2.9 billion for Q3 2025, which was up 328.78% from $2.9 billion recorded in Q2 2025.
  • In the past 5 years, Repligen's Liabilities and Shareholders Equity ranged from a high of $2.9 billion in Q3 2025 and a low of $1.9 billion during Q1 2021
  • Its 5-year average for Liabilities and Shareholders Equity is $2.6 billion, with a median of $2.5 billion in 2023.
  • Per our database at Business Quant, Repligen's Liabilities and Shareholders Equity surged by 5182.37% in 2021 and then dropped by 5.43% in 2025.
  • Over the past 5 years, Repligen's Liabilities and Shareholders Equity (Quarter) stood at $2.4 billion in 2021, then rose by 7.35% to $2.5 billion in 2022, then increased by 11.83% to $2.8 billion in 2023, then decreased by 0.05% to $2.8 billion in 2024, then increased by 3.32% to $2.9 billion in 2025.
  • Its last three reported values are $2.9 billion in Q3 2025, $2.9 billion for Q2 2025, and $2.9 billion during Q1 2025.